Testing antibody findings to confirm autoimmune low platelets
Treatments studied
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- Your platelet count is under 100, measured twice, and follow-up tests show it is real (not a lab artifact) and not acute leukemia
- You have not started any treatment for low platelets yet (except up to 48 hours of corticosteroids may be allowed)
- You can sign informed consent, and you are covered by a social security health plan
- You are not pregnant or breastfeeding, and you are not under legal guardianship or similar protections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study looks at blood and immune system patterns in adults with primary immune thrombocytopenia (ITP) who are starting their first treatment. The goal is to better understand what’s happening in ITP, which may improve how future patients are cared for.
This study tests whether adding another medicine (telitacicept) to a standard platelet-boosting drug (eltrombopag) works better than eltrombopag alone for adults with ITP that hasn't improved with steroids. The goal is to help raise your platelet counts and reduce bleeding risk.
This study looks at levels of two proteins (interleukin-1β and interleukin-33) in your blood to better understand and tell apart two conditions that cause low platelets. It may help doctors improve diagnosis and treatment for people with these conditions.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
This early-phase trial is testing a new cell therapy for people with certain autoimmune diseases where the immune system attacks blood platelets, causing bleeding problems. The treatment is designed to stop this attack and could be an option if standard medications haven't worked.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.